Psoriasis assessment tools in clinical trials
- PMID: 15708941
- PMCID: PMC1766877
- DOI: 10.1136/ard.2004.031237
Psoriasis assessment tools in clinical trials
Abstract
In clinical practice, broad global assessments of psoriasis disease activity and its effect on patients' quality of life are used to assess the severity of patients' disease and their response to treatment. In clinical trials, more objective, validated instruments are required. Several such instruments have been developed and continue to be developed to provide an assessment of the severity of the skin lesions. Because a lesion's impact on patients' lives varies widely among patients, there has been growing recognition of the need to measure the quality of life impact of the disease along with the severity of the lesions.
Similar articles
-
Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative.Am J Clin Dermatol. 2020 Jun;21(3):323-338. doi: 10.1007/s40257-019-00496-w. Am J Clin Dermatol. 2020. PMID: 31950353
-
Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice.Dermatol Clin. 2015 Jan;33(1):57-71. doi: 10.1016/j.det.2014.09.005. Dermatol Clin. 2015. PMID: 25412783 Review.
-
Psoriatic arthritis assessment tools in clinical trials.Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii49-54. doi: 10.1136/ard.2004.034165. Ann Rheum Dis. 2005. PMID: 15708937 Free PMC article. Review.
-
Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.Health Qual Life Outcomes. 2003 Oct 8;1:53. doi: 10.1186/1477-7525-1-53. Health Qual Life Outcomes. 2003. PMID: 14613569 Free PMC article. Clinical Trial.
-
Clinical outcome measures of psoriasis.Reumatismo. 2007;59 Suppl 1:64-7. doi: 10.4081/reumatismo.2007.1s.64. Reumatismo. 2007. PMID: 17828348
Cited by
-
Ocular manifestations in moderate-to-severe psoriasis in India: A prospective observational study.Indian J Ophthalmol. 2022 Sep;70(9):3328-3332. doi: 10.4103/ijo.IJO_551_22. Indian J Ophthalmol. 2022. PMID: 36018114 Free PMC article.
-
The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland.Mediators Inflamm. 2015;2015:194535. doi: 10.1155/2015/194535. Epub 2015 Jun 4. Mediators Inflamm. 2015. PMID: 26146462 Free PMC article.
-
Application of the GRAPPA psoriatic arthritis treatment recommendations in clinical practice.Curr Rheumatol Rep. 2010 Aug;12(4):264-71. doi: 10.1007/s11926-010-0109-y. Curr Rheumatol Rep. 2010. PMID: 20440659 Review.
-
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning.Arthritis Res Ther. 2022 Jun 24;24(1):153. doi: 10.1186/s13075-022-02838-2. Arthritis Res Ther. 2022. PMID: 35751091 Free PMC article.
-
Oxidative Stress Induced by High Salt Diet-Possible Implications for Development and Clinical Manifestation of Cutaneous Inflammation and Endothelial Dysfunction in Psoriasis vulgaris.Antioxidants (Basel). 2022 Jun 27;11(7):1269. doi: 10.3390/antiox11071269. Antioxidants (Basel). 2022. PMID: 35883760 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical